# L2 Diagnostics LLC

Canonical: https://abierto.us/vendors/l2-diagnostics-llc-gka7vh5lfr25

- UEI: GKA7VH5LFR25
- CAGE: 43BA5
- Location: New Haven, CT
- Awards in window: 2 (5 transactions), $899,471 obligated, December 3, 2024 to July 22, 2026

## Awarding agencies

- National Institutes of Health: 2 awards, $899,471

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $599,471
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $300,000

## Competition

- Full and Open Competition After Exclusion of Sources: 2 awards

## Largest awards

- 75N93025C00024 (definitive contract): $599,471, National Institutes of Health Niaid. Therapeutic Vaccine Platform to Boost Immune Responses in Tuberculosis. https://www.usaspending.gov/award/CONT_AWD_75N93025C00024_7529_-NONE-_-NONE-/
- 75N93025C00004 (definitive contract): $300,000, National Institutes of Health Niaid. Novel Diagnostic Biomarkers Discovery and Validation for Malaria SBIR Phase I. https://www.usaspending.gov/award/CONT_AWD_75N93025C00004_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/l2-diagnostics-llc-gka7vh5lfr25.